Answers are grounded in this paper and cite their sources.
Background: Comorbidities found high rates of psychiatric comorbidity among people with substance use disorders. Mood and anxiety disorders are the most frequent. Objective: To evaluate the psychometric properties of the Center for Epidemiologic Studies Depression Scale (CES-D) for a clinical sample of people with a drug addiction diagnosis. Method: 513 outpatients from two public health services for substance abuse treatment participated in this study. To assess the construct validity in our sample, we used a confirmatory factorial analysis (CFA), comparing two previous versions of CES-D that had evidence of validity for other Brazilian populations. Divergent and convergent validity was evaluated using Pearson's correlation test. Reliability coefficients were calculated by Cronbach's alpha (α) and average split-half test. Results: A four dimensions structure fitted well to our data with a better performance. Convergent validity was supported by a moderate positive correlation between CES-D factors and self-stigma. Divergent validity was supported by a negative moderated correlation with hope and self-esteem. Conclusions: The psychometric properties of our proposed model supports the use of CES-D to evaluate depression symptoms among people in treatment for substance use disorders.
No takes yet. Share an insight, caveat, or question.
Ronzani et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: